162 related articles for article (PubMed ID: 38717519)
1. A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
Baugh AG; Gonzalez E; Narumi VH; Kreger J; Liu Y; Rafie C; Castanon S; Jang J; Kagohara LT; Anastasiadou DP; Leatherman J; Armstrong T; Chan I; Karagiannis GS; Jaffee EM; MacLean A; Torres ETR
Clin Exp Metastasis; 2024 May; ():. PubMed ID: 38717519
[TBL] [Abstract][Full Text] [Related]
2. Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2
Baugh AG; Gonzalez E; Narumi VH; Kreger J; Liu Y; Rafie C; Castanon S; Jang J; Kagohara LT; Anastasiadou DP; Leatherman J; Armstrong TD; Chan I; Karagiannis GS; Jaffee EM; MacLean A; Roussos Torres ET
bioRxiv; 2024 Jan; ():. PubMed ID: 38352476
[TBL] [Abstract][Full Text] [Related]
3. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model.
Li W; Li S; Chen IX; Liu Y; Ramjiawan RR; Leung CH; Gerweck LE; Fukumura D; Loeffler JS; Jain RK; Duda DG; Huang P
Radiat Oncol; 2021 Mar; 16(1):48. PubMed ID: 33663521
[TBL] [Abstract][Full Text] [Related]
4. An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.
Song H; Shahverdi K; Huso DL; Wang Y; Fox JJ; Hobbs RF; Gimi B; Gabrielson KL; Pomper MG; Tsui BM; Bhujwalla Z; Reilly RT; Sgouros G
Clin Cancer Res; 2008 Oct; 14(19):6116-24. PubMed ID: 18829490
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2
Nagpal A; Redvers RP; Ling X; Ayton S; Fuentes M; Tavancheh E; Diala I; Lalani A; Loi S; David S; Anderson RL; Smith Y; Merino D; Denoyer D; Pouliot N
Breast Cancer Res; 2019 Aug; 21(1):94. PubMed ID: 31409375
[TBL] [Abstract][Full Text] [Related]
7. Identification of prospective factors promoting osteotropism in breast cancer: a potential role for CITED2.
Lau WM; Weber KL; Doucet M; Chou YT; Brady K; Kowalski J; Tsai HL; Yang J; Kominsky SL
Int J Cancer; 2010 Feb; 126(4):876-84. PubMed ID: 19642106
[TBL] [Abstract][Full Text] [Related]
8. Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV.f.HuHER2 mice: characterization and use in a model of metastatic breast cancer.
Park S; Nedrow JR; Josefsson A; Sgouros G
Oncotarget; 2017 Sep; 8(40):68071-68082. PubMed ID: 28978097
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity impacts the response to anti-neu antibody therapy.
Song H; Kim TO; Ma SY; Park JH; Choi JH; Kim JH; Kang MS; Bae SK; Kim KH; Kim TH; Seo SK; Choi IW; Song GA; Mortenson ED; Fu YX; Park S
BMC Cancer; 2014 Sep; 14():647. PubMed ID: 25179116
[TBL] [Abstract][Full Text] [Related]
10. Development of Novel Patient-Derived Xenografts from Breast Cancer Brain Metastases.
Contreras-Zárate MJ; Ormond DR; Gillen AE; Hanna C; Day NL; Serkova NJ; Jacobsen BM; Edgerton SM; Thor AD; Borges VF; Lillehei KO; Graner MW; Kabos P; Cittelly DM
Front Oncol; 2017; 7():252. PubMed ID: 29164052
[TBL] [Abstract][Full Text] [Related]
11. Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.
Johnstone CN; Smith YE; Cao Y; Burrows AD; Cross RS; Ling X; Redvers RP; Doherty JP; Eckhardt BL; Natoli AL; Restall CM; Lucas E; Pearson HB; Deb S; Britt KL; Rizzitelli A; Li J; Harmey JH; Pouliot N; Anderson RL
Dis Model Mech; 2015 Mar; 8(3):237-51. PubMed ID: 25633981
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Multi-Institutional Observational Study on ER, PR, HER2/NEU, and Ki-67 Expression and Discordance Pattern in Primary and Metastatic and Recurrent Carcinoma Breast and Its Therapeutic Implications and Prognostic Outcome.
Satishkumar M; Ramesh M; Sanjive JG
Indian J Surg Oncol; 2023 Mar; 14(1):72-80. PubMed ID: 36891419
[TBL] [Abstract][Full Text] [Related]
14. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
15. Animal models of bone metastasis.
Rosol TJ; Tannehill-Gregg SH; LeRoy BE; Mandl S; Contag CH
Cancer; 2003 Feb; 97(3 Suppl):748-57. PubMed ID: 12548572
[TBL] [Abstract][Full Text] [Related]
16. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
Soran A; Ozbas S; Ozcinar B; Isik A; Dogan L; Senol K; Dag A; Karanlik H; Aytac O; Karadeniz Cakmak G; Dalci K; Dogan M; Sezer YA; Gokgoz S; Ozyar E; Sezgin E;
Ann Surg Oncol; 2022 Oct; 29(10):6327-6336. PubMed ID: 35876920
[TBL] [Abstract][Full Text] [Related]
17. Generation and characterisation of two D2A1 mammary cancer sublines to model spontaneous and experimental metastasis in a syngeneic BALB/c host.
Jungwirth U; van Weverwijk A; Melake MJ; Chambers AF; Gao Q; Fivaz M; Isacke CM
Dis Model Mech; 2018 Jan; 11(1):. PubMed ID: 29208627
[TBL] [Abstract][Full Text] [Related]
18. Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Razmara AM; Sollier E; Kisirkoi GN; Baker SW; Bellon MB; McMillan A; Lemaire CA; Ramani VC; Jeffrey SS; Casey KM
Clin Exp Metastasis; 2020 Jun; 37(3):413-424. PubMed ID: 32335861
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Selection of Intermediately- and Highly-Malignant Variants of Triple-negative Breast Cancer in Orthotopic Nude Mouse Models.
Yano S; Takehara K; Kishimoto H; Tazawa H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
Anticancer Res; 2016 Dec; 36(12):6273-6277. PubMed ID: 27919946
[TBL] [Abstract][Full Text] [Related]
20. Surgically-Induced Multi-organ Metastasis in an Orthotopic Syngeneic Imageable Model of 4T1 Murine Breast Cancer.
Zhang Y; Zhang N; Hoffman RM; Zhao M
Anticancer Res; 2015 Sep; 35(9):4641-6. PubMed ID: 26254353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
